High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma

Over the years, molecular subtypes based on estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER-2) status have been observed to effectively guide decision-making for the optimal treatment of patients with breast carcinoma (BRCA). However, despite thi...

Full description

Bibliographic Details
Main Authors: Gaoda Ju, Cheng Xu, Kai Zeng, Tianhao Zhou, Lijuan Zang
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Bioengineered
Subjects:
Online Access:http://dx.doi.org/10.1080/21655979.2021.1990673